Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thymidine Phosphorylase / PD-ECGF (Angiogenesis Marker) (P-GF.44C), 1mg/mL | Login | Thymidine Phosphorylase / PD-ECGF (Angiogenesis Marker) (P-GF.44C), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| E-Cadherin / CD324 (Intercellular Junction Marker) (CDH1/1525), 1mg/mL | Login | E-Cadherin / CD324 (Intercellular Junction Marker) (CDH1/1525), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Bcl-6 (Follicular Lymphoma Marker) (BCL6/1526), 1mg/mL | Login | Bcl-6 (Follicular Lymphoma Marker) (BCL6/1526), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Bcl-6 (Follicular Lymphoma Marker) (BCL6/1527), 1mg/mL | Login | Bcl-6 (Follicular Lymphoma Marker) (BCL6/1527), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| IL3RA / CD123 (Acute Myeloid Leukemia Marker)(IL3RA/1531), 1mg/mL | Login | IL3RA / CD123 (Acute Myeloid Leukemia Marker)(IL3RA/1531), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16 (CDH16/1532R), 1mg/mL | Login | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16 (CDH16/1532R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R), 1mg/mL | Login | Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (GPC3/1534R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Desmoglein-3 (Squamous Cell Marker) (DSG3/1535), 1mg/mL | Login | Desmoglein-3 (Squamous Cell Marker) (DSG3/1535), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker), 1mg/mL | Login | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Beta-2 Microglobulin (Renal Failure & Tumor Marker)(rB2M/961), 1mg/mL | Login | Beta-2 Microglobulin (Renal Failure & Tumor Marker)(rB2M/961), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Ep-CAM / CD326 (Epithelial Marker) (EGP40/1555R), 1mg/mL | Login | Ep-CAM / CD326 (Epithelial Marker) (EGP40/1555R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Ep-CAM / CD326 (Epithelial Marker) (EGP40/1556R), 1mg/mL | Login | Ep-CAM / CD326 (Epithelial Marker) (EGP40/1556R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker) (TYRP1/1564R), 1mg/mL | Login | Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker) (TYRP1/1564R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| GCDFP-15 (Gross Cystic Disease Fluid Protein 15) (Breast Marker) (PIP/1571), 1mg/mL | Login | GCDFP-15 (Gross Cystic Disease Fluid Protein 15) (Breast Marker) (PIP/1571), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| N-Cadherin / Cadherin-2 / CD325 (NCAD) (CDH2/1573), 1mg/mL | Login | N-Cadherin / Cadherin-2 / CD325 (NCAD) (CDH2/1573), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| HIF1 alpha (Hypoxia-Inducible Factor 1-alpha)(ESEE122), 1mg/mL | Login | HIF1 alpha (Hypoxia-Inducible Factor 1-alpha)(ESEE122), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker), 1mg/mL | Login | Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| CD22 / BL-CAM (B-Cell Marker)(RFB4), 1mg/mL | Login | CD22 / BL-CAM (B-Cell Marker)(RFB4), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| CD56 / NCAM1 / NKH1 (Neuronal Cell Marker)(ERIC-1), 1mg/mL | Login | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker)(ERIC-1), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| CD4 (T-Helper/Inducer Cell Marker)(CD4/1604), 1mg/mL | Login | CD4 (T-Helper/Inducer Cell Marker)(CD4/1604), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| CD40 / TNFRSF5 (C40/1605), 1mg/mL | Login | CD40 / TNFRSF5 (C40/1605), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| CD51 / Integrin V(ITGAV/1610), 1mg/mL | Login | CD51 / Integrin V(ITGAV/1610), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| CD27 (Tumor Necrosis Factor Receptor Superfamily 7) (LPFS2/1611), 1mg/mL | Login | CD27 (Tumor Necrosis Factor Receptor Superfamily 7) (LPFS2/1611), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| CD44 / HCAM Std.(BU75), 1mg/mL | Login | CD44 / HCAM Std.(BU75), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| CD10 (Membrane Metalloendopeptidase)(MME/1620), 1mg/mL | Login | CD10 (Membrane Metalloendopeptidase)(MME/1620), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||


